Literature DB >> 7838428

Up-regulation of ERK (MAP kinase) and MEK (MAP kinase kinase) transcription after rat facial nerve transection.

T Kitahara1, S Kiryu, K Ohno, N Morita, T Kubo, H Kiyama.   

Abstract

Up-regulation of ERK (extracellular signal-regulated kinase or MAP kinase) and MEK (ERK kinase or MAPK kinase) expression after rat facial nerve injury was demonstrated by in situ hybridization histochemistry and immunohistochemistry. These two enzymes play roles in one of the major intracellular signal cascade pathways involving receptor tyrosine kinase common to growth factor receptors, and transcription factors. Significant increases in ERK1 mRNA levels were observed from day 3 after facial nerve transection, with the highest level of expression from 1 to 2 weeks after the operation. This high level of mRNA expression then decreased gradually to the normal level. ERK1-like immunoreactivity showed a similar time course to that of its mRNA expression; however, the decay profile was more prolonged. The up-regulation of MEK, the ERK kinase/MAPK kinase, was also detected by immunohistochemistry. The protein expression profiles were almost equivalent, but the MEK expression was slightly advanced, suggesting that the observed up-regulation of MEK was not due to that of ERK. The receptor tyrosine kinase signal transduction pathway via MEK-ERK located downstream of growth factor receptors seems vital as a regulator of the synthesis of molecules that play important roles in the recovery process following injury or/and regeneration.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7838428     DOI: 10.1016/0168-0102(94)90097-3

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  9 in total

Review 1.  Priming events and retrograde injury signals. A new perspective on the cellular and molecular biology of nerve regeneration.

Authors:  R T Ambron; E T Walters
Journal:  Mol Neurobiol       Date:  1996-08       Impact factor: 5.590

2.  Cellular expression of MAP 2 kinase in rat brain.

Authors:  D M Jacobowitz; L Winsky; S D Detera-Wadleigh
Journal:  Histochem Cell Biol       Date:  1996-09       Impact factor: 4.304

3.  Axotomy-induced loss of m2 muscarinic receptor mRNA in the rat facial motor nucleus precedes a decrease in concentration of muscarinic receptors.

Authors:  D B Hoover; R H Baisden; J V Lewis
Journal:  Histochem J       Date:  1996-11

4.  The small GTP-binding protein TC10 promotes nerve elongation in neuronal cells, and its expression is induced during nerve regeneration in rats.

Authors:  K Tanabe; T Tachibana; T Yamashita; Y H Che; Y Yoneda; T Ochi; M Tohyama; H Yoshikawa; H Kiyama
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

5.  Damage-induced neuronal endopeptidase (DINE) is a unique metallopeptidase expressed in response to neuronal damage and activates superoxide scavengers.

Authors:  S Kiryu-Seo; M Sasaki; H Yokohama; S Nakagomi; T Hirayama; S Aoki; K Wada; H Kiyama
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

6.  Effects of smoking cessation on gene expression in human leukocytes of chronic smoker.

Authors:  Soo-Jeong Kim; Su Young Kim; Jae Hwa Kim; Dai-Jin Kim
Journal:  Psychiatry Investig       Date:  2014-07-21       Impact factor: 2.505

7.  The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC.

Authors:  Lei Li; Guo-Dong Zhao; Zhe Shi; Li-Li Qi; Li-Yuan Zhou; Ze-Xian Fu
Journal:  Oncol Lett       Date:  2016-09-09       Impact factor: 2.967

Review 8.  Events Occurring in the Axotomized Facial Nucleus.

Authors:  Kazuyuki Nakajima; Takashi Ishijima
Journal:  Cells       Date:  2022-06-29       Impact factor: 7.666

9.  p38 mitogen-activated protein kinase determines the susceptibility to cigarette smoke-induced emphysema in mice.

Authors:  Satoshi Marumo; Yuma Hoshino; Hirofumi Kiyokawa; Naoya Tanabe; Atsuyasu Sato; Emiko Ogawa; Shigeo Muro; Toyohiro Hirai; Michiaki Mishima
Journal:  BMC Pulm Med       Date:  2014-05-07       Impact factor: 3.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.